PDMR Dealing

CVS Group plc

06 August 2026

 

6 August 2026

CVS Group plc

("CVS" or the "Company")

PDMR Dealing

CVS, the UK's listed veterinary group and a leading provider of veterinary services, announces that it was notified on 6 August 2026 that Robin Alfonso, Chief Financial Officer of the Company, purchased a total of 768 ordinary shares of 0.2p each in the Company ("Ordinary Shares") on the same date.

As a result, Robin Alfonso's total interest in the Company, including all persons closely associated, is now at 26,015 Ordinary Shares, representing 0.038% per cent of the total voting rights of the Company.

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

Contacts:

CVS Group plc Richard Fairman, CEO Scott Morrison, Company Secretary	via FGS Global
FGS Global (Financial PR) Faeth Birch Charlie Chichester	[phone] [e-mail]

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Robin Alfonso
2	Reason for the notification
a)	Position/status	PDMR (Chief Financial Officer)
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	CVS Group plc
b)	LEI	213800J41XDQ2NX48O05
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 0.2 pence each GB00B2863827
b)	Nature of the transaction	On-market purchase
c)	Price(s) and volume(s)	Price(s) - pence Volume(s) 1,294.2662 768
d)	Aggregated information - Aggregated volume - Price	N/A - single transaction
e)	Date of the transaction	6 August 2026
f)	Place of the transaction	London Stock Exchange (XLON)

 

END